No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study

Prior studies suggested that the use of androgen deprivation therapy (ADT) in patients with prostate cancer (PC) might cause the impairment of cognitive function which is one of the common symptoms of dementia; however, the association between ADT and cognitive impairment still remains controversial...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Li-Ting, Lin, Herng-Ching, Chung, Shiu-Dong, Huang, Chao-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507085/
https://www.ncbi.nlm.nih.gov/pubmed/27232853
http://dx.doi.org/10.4103/1008-682X.179528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507085/
https://www.ncbi.nlm.nih.gov/pubmed/27232853
http://dx.doi.org/10.4103/1008-682X.179528

Ejemplares similares